Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B E Gidal

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Archives of Internal Medicine|December 22, 1999
Guidelines for nonemergency use of parenteral phenytoin products: proceedings of an expert panel consensus process. Panel on Nonemergency Use of Parenteral Phenytoin ProductsP D Meek, S N Davis, D M Collins, et al.
Clinical Pharmacology and Therapeutics|August 1, 1996
Bidirectional interaction of valproate and lamotrigine in healthy subjectsG D Anderson, M K Yau, B E Gidal, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 1, 1996
Warfarin-fluconazole. II. A metabolically based drug interaction: in vivo studiesD J Black, K L Kunze, L C Wienkers, et al.
The American Journal of Managed Care|July 28, 2001
Managing healthcare resources appropriately. Roundtable discussionI E Leppik, J A French, G K Bergey, et al.
Acta Neurologica Scandinavica|May 8, 2018
Exposure-safety and efficacy response relationships and population pharmacokinetics of eslicarbazepine acetateB E Gidal, M P Jacobson, E Ben-Menachem, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Archives of Internal Medicine|December 22, 1999
Guidelines for nonemergency use of parenteral phenytoin products: proceedings of an expert panel consensus process. Panel on Nonemergency Use of Parenteral Phenytoin ProductsP D Meek, S N Davis, D M Collins, et al.
Clinical Pharmacology and Therapeutics|August 1, 1996
Bidirectional interaction of valproate and lamotrigine in healthy subjectsG D Anderson, M K Yau, B E Gidal, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 1, 1996
Warfarin-fluconazole. II. A metabolically based drug interaction: in vivo studiesD J Black, K L Kunze, L C Wienkers, et al.
The American Journal of Managed Care|July 28, 2001
Managing healthcare resources appropriately. Roundtable discussionI E Leppik, J A French, G K Bergey, et al.
Acta Neurologica Scandinavica|May 8, 2018
Exposure-safety and efficacy response relationships and population pharmacokinetics of eslicarbazepine acetateB E Gidal, M P Jacobson, E Ben-Menachem, et al.
Pageof 6